Please assess the completion status of the following clinical trial:

Trial Title: An Observational Study of MabThera in Participants With Severe Active Rheumatoid Arthritis

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Age \>18 years with rheumatoid arthritis (RA)~* Seropositive participants with RA (positive for rheumatoid factor (RF) and/or anti-Citrullinated Cyclic Peptide \[CCP\])~* Active disease despite receiving one or more TNF inhibitors~* Absence of serious or active infection~Exclusion Criteria:~* Participants with serious history of heart failure (class New York Heart Association \[NYHA\] IV) or severe uncontrolled heart disease~* Participants pregnant or lactating~* Prior treatment with Mabthera®~* Participants receiving any other investigational product in the context of other clinical study~* Participants with known hypersensitivity to rituximab or to any of the excipients

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Rituximab (Type: None): Rituximab administered according to prescribing information and normal clinical practice.

Based on this trial design, predict the completion outcome and termination type (if applicable).